PI3K inhibitors in inflammation, autoimmunity and cancer
Author:
Funder
BBSRC
Wellcome Trust
GlaxoSmithKline
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference81 articles.
1. PI3K signalling in inflammation;Hawkins;Biochim Biophys Acta,2015
2. Signaling by the phosphoinositide 3-kinase family in immune cells;Okkenhaug;Annu Rev Immunol,2013
3. Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies;Foster;Pharmacol Rev,2012
4. Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kgamma, a single convergent point promoting tumor inflammation and progression;Schmid;Cancer Cell,2011
5. PI3K and cancer: lessons, challenges and opportunities;Fruman;Nat Rev Drug Discov,2014
Cited by 243 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mitigation of Allergic Asthma in Mice: A Compound Mixture Comprising Luteolin, Arbutin, and Marmesin from Gerbera Piloselloides Herba by Suppression of PI3K/Akt Pathway;Heliyon;2024-09
2. Activated phosphoinositide 3‐kinase delta syndrome: Pathogenesis, clinical manifestations, and treatment;Pediatric Discovery;2024-08-23
3. Discovery of Pyrazolo[1,5-a]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors;Journal of Medicinal Chemistry;2024-08-20
4. Predict the Drug–Drug Interaction of a Novel PI3Kα/δ Inhibitor, TQ‐B3525, and Its Two Metabolites Using Physiologically Based Pharmacokinetic Modeling;The Journal of Clinical Pharmacology;2024-08-06
5. Analysis of the Protective Effects of Rosa roxburghii-Fermented Juice on Lipopolysaccharide-Induced Acute Lung Injury in Mice through Network Pharmacology and Metabolomics;Nutrients;2024-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3